1993 …2023
If you made any changes in Pure, your changes will be visible here soon.

Projects 1993 2023

Serum Albumin
human F8 protein
Safety
Venous Thrombosis
Observational Studies
Orthopedics
Hemophilia A
Pharmacokinetics
Safety
BAY 94-9027
Hemophilia B
Factor IX
Genetic Therapy
Viruses
Serogroup
Hemophilia B
Dependovirus
Factor IX
Genetic Therapy
Serogroup
Hemophilia A
Safety
BAY 94-9027
Hemophilia B
Factor IX
Blood Coagulation Factors
Factor VIII
Hemophilia A
Factor VIII
Hemophilia A
Hemorrhage
Patient Reported Outcome Measures
Phase III Clinical Trials
Hemophilia A
Pharmacokinetics
Safety
Genetic Therapy

Clinical Trials in Transfusion Medicine and Hemostasis

Mc Cullough, J., Clay, M. & Reding, M. T.

NIH Nat'l Heart, Lung, and Blood Inst.

9/1/078/31/14

Project: Research project

Transfusion Medicine
Hemostasis
Clinical Trials
Blood Platelets
Hemorrhage
Hemophilia A
Observational Studies
Hemophilia A
Registries
Patient Reported Outcome Measures
Hemophilia A
Hemorrhage
Safety
Therapeutics
United States Health Resources and Services Administration
United States Health Resources and Services Administration
Factor VIII
Genetic Therapy

MASTER: TMH Network Master Site Agreement

Mc Cullough, J., Clay, M., Reding, M. T. & Steiner, M. E.

New England Research Institutes

9/1/078/31/14

Project: Research project

OBI-1 Open Label

Reding, M. T.

OCTAGEN CORP

2/10/0512/31/07

Project: Research project

Hemophilia B
Factor IX
Pharmacokinetics
Outcome Assessment (Health Care)
IB1001
Type 3 Von Willebrand's Disease
Factor VIII
Safety
Clinical Studies
human F8 protein
Public Health Surveillance
Hemorrhage
Neutropenia
Granulocytes
Infection
United States Health Resources and Services Administration
Hemophilia A